Skip to main content
FinSpry Logo
FinSpry
RYTM logo
RYTM
(NASDAQ)
Rhythm Pharmaceuticals, Inc.
$102.66-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Rhythm Pharmaceuticals (RYTM) Stock Price & Financial Analysis

Rhythm Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$101.04 - $103.32
52-Week High$122.20
52-Week Low$74.50
Open$101.64
Volume447.56K
Average Volume (3M)913.06K
Market Cap6.98B
Shares Outstanding67.97M
Price to Sales (P/S)32.13
Price to Book (P/B)56.78
EV/EBITDA-39.52
Revenue (TTM)217.16M
Net Income (TTM)-202.68M
Free Cash Flow (TTM)-120.46M
EPS (TTM)$-3.06
Profit Margin-93.33%
Operating Margin-90.89%
Return on Equity (ROE)-164.91%
Debt to Equity1.85
50-Day MA$98.28
200-Day MA$98.89
52-Week Change16.91%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Rhythm Pharmaceuticals

What is the current stock price for RYTM?

As of the latest trading session, RYTM stock trades at $102.66. The 52-week range is $74.50–$122.20, with a day range of $101.04–$103.32.

What is the P/E ratio for RYTM?

The P/E ratio (Price-to-Earnings) for RYTM is shown in the Key Statistics section. This valuation metric helps compare Rhythm Pharmaceuticals, Inc. to industry peers.

Does RYTM pay dividends?

Rhythm Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RYTM?

Based on 10 analysts, the consensus for RYTM is Buy.

What is the market cap of RYTM?

Rhythm Pharmaceuticals's market capitalization is $6.98B, classifying it as a mid-cap company. Rhythm Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.